TY - JOUR
T1 - Direct conversion of cord blood CD34+ cells into neural stem cells by OCT4
AU - Liao, Wenbin
AU - Huang, Nick
AU - Yu, Jingxia
AU - Jares, Alexander
AU - Yang, Jianchang
AU - Zieve, Gary
AU - Avila, Cecilia
AU - Jiang, Xun
AU - Zhang, Xiao Bing
AU - Ma, Yupo
N1 - Publisher Copyright:
© 2015 AlphaMed Press.
PY - 2015/7/1
Y1 - 2015/7/1
N2 - Cellular reprogramming or conversion is a promising strategy to generate desired stem cell types from somatic cells. Neural stem cells (NSCs) have the potential to regenerate central nervous system tissue and repair damage in response to injury. However, NSCs are difficult to isolate fromhumantissues and expand in sufficient quantities for therapy. Here, we report a method to generate neural stem cells from cord blood CD34-positive cells by ectopic expression of OCT4 in a feeder-free system. The induced cells (iNSCs) show a characteristic NSC-like morphology and can be expanded in vitro for more than 20 passages. In addition, the iNSCs are positive for neural stem cell-specific markers such as Nestin and Musashi-1 and are similar in gene expression patterns to a human neural stem cell line. The iNSCs express distinct transcriptional factors for forebrain, hindbrain, and spinal cord regions. Upon differentiation, the iNSCs are able to commit into multilineage mature neural cells. Following in vivo introduction into NOD/SCID mice, iNSCs can survive and differentiate in the mouse brain 3 months post-transplantation. Alternatively, we were also able to derive iNSCs with an episomal vector expressing OCT4. Our results suggest a novel, efficient approach to generate neural precursor cells that can be potentially used in drug discovery or regenerative medicine for neurological disease and injury.
AB - Cellular reprogramming or conversion is a promising strategy to generate desired stem cell types from somatic cells. Neural stem cells (NSCs) have the potential to regenerate central nervous system tissue and repair damage in response to injury. However, NSCs are difficult to isolate fromhumantissues and expand in sufficient quantities for therapy. Here, we report a method to generate neural stem cells from cord blood CD34-positive cells by ectopic expression of OCT4 in a feeder-free system. The induced cells (iNSCs) show a characteristic NSC-like morphology and can be expanded in vitro for more than 20 passages. In addition, the iNSCs are positive for neural stem cell-specific markers such as Nestin and Musashi-1 and are similar in gene expression patterns to a human neural stem cell line. The iNSCs express distinct transcriptional factors for forebrain, hindbrain, and spinal cord regions. Upon differentiation, the iNSCs are able to commit into multilineage mature neural cells. Following in vivo introduction into NOD/SCID mice, iNSCs can survive and differentiate in the mouse brain 3 months post-transplantation. Alternatively, we were also able to derive iNSCs with an episomal vector expressing OCT4. Our results suggest a novel, efficient approach to generate neural precursor cells that can be potentially used in drug discovery or regenerative medicine for neurological disease and injury.
KW - Cord blood
KW - Direct conversion
KW - Neural stem cell
KW - OCT4
UR - http://www.scopus.com/inward/record.url?scp=84937022329&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84937022329&partnerID=8YFLogxK
U2 - 10.5966/sctm.2014-0289
DO - 10.5966/sctm.2014-0289
M3 - Article
SN - 2157-6564
VL - 4
SP - 755
EP - 763
JO - Stem Cells Translational Medicine
JF - Stem Cells Translational Medicine
IS - 7
ER -